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Abstract
Background: In emergency research, obtaining informed consent can be problematic. Research to
develop and improve treatments for patients admitted to hospital with life-threatening and debilitating
conditions is much needed yet the issue of research without consent (RWC) raises concerns about
unethical practices and the loss of individual autonomy. Consistent with the policy and practice turn
towards greater patient and public involvement in health care decisions, in the US, Canada and EU,
guidelines and legislation implemented to protect patients and facilitate acute research with adults who are
unable to give consent have been developed with little involvement of the lay public. This paper reviews
research examining public opinion regarding RWC for research in emergency situations, and whether the
rules and regulations permitting research of this kind are in accordance with the views of those who
ultimately may be the most affected.
Methods: Seven electronic databases were searched: Medline, Embase, CINAHL, Cochrane Database of
Systematic Reviews, Philosopher's Index, Age Info, PsychInfo, Sociological Abstracts and Web of Science.
Only those articles pertaining to the views of the public in the US, Canada and EU member states were
included. Opinion pieces and those not published in English were excluded.
Results: Considering the wealth of literature on the perspectives of professionals, there was relatively
little information about public attitudes. Twelve studies employing a range of research methods were
identified. In five of the six questionnaire surveys around half the sample did not agree generally with RWC,
though paradoxically, a higher percentage would personally take part in such a study. Unfortunately most
of the studies were not designed to investigate individuals' views in any depth. There also appears to be a
level of mistrust of medical research and some patients were more likely to accept an experimental
treatment 'outside' of a research protocol.
Conclusion: There are too few data to evaluate whether the rules and regulations permitting RWC
protects – or is acceptable to – the public. However, any attempts to engage the public should take place
in the context of findings from further basic research to attend to the apparently paradoxical findings of
some of the current surveys.
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Background
Few people would disagree with the need to conduct acute
clinical research to develop and improve methods of treat-
ing patients admitted to hospital with life-threatening and
debilitating conditions. In these circumstances obtaining
informed consent can be problematic. Patients may ini-
tially be unconscious, in shock or have some cognitive
impairment, and if the study intervention has a short ther-
apeutic window there is little time to locate a proxy for
consent. It follows, therefore, that for research of this kind
to proceed with patients who have impaired decision-
making capacity, in some patients it must do so without
their consent. This illustrates the key ethical dilemma of
allowing acute research in which society as a whole will
benefit, whilst maintaining respect for the individuals
who contribute to that research[1]. Given the turn
towards greater patient and public involvement in health
care decisions [2] following the events of the 20th century
relating to human subject research, research without con-
sent clearly raises concerns about unethical practices [3-5]
and the loss of individual autonomy[6] that is "respect for
the patient's capacity of self-determination, and exercise
of personal choice"[7]. The subject of considerable debate
among researchers, medical ethicists and philosophers for
a number of years, the overriding objection to waiving
individual informed consent is that it erodes patient
autonomy. However, some point out autonomy is not the
sole applicable ethical principle and those involved in
research have a duty – in respect to the principle of justice
– to develop potentially beneficial therapies that are avail-
able to all populations[8,9]. Others have questioned the
equity of excluding patients where individual or proxy
consent is not possible and denying them the right to par-
ticipate and to any potential benefits[10,11]. Opinion
regarding informed consent ranges from the view that (in
certain circumstances) the process is 'needlessly cruel'[12]
and violates the principle of beneficence for some
patients[13], to concerns that it should always  be
obtained[14,15] and permitting waiver of consent is a
slippery slope toward unethical practices[16]. At the same
time, emergency researchers are frustrated by a somewhat
paradoxical situation where physicians are free to pre-
scribe, without ethical approval, a medication for their
own patients that has not been tested scientifically with
that particular medical condition [17-20].
Research without consent (RWC) is currently permissible
in certain situations under specific conditions in the US,
EU member states, Canada, and Australasia. In the US it
has been argued that these regulations (Food and Drug
Administration. 21 CFR 50.24 – Exception from Informed
Consent) have led to a reduction in the number of emer-
gency medicine studies implemented [21]. Although a
published review of journal articles (up to 2004) and FDA
information (up to 2003) identified only five studies as
being conducted under the US regulations since their
implementation in 1996 [22], at a Food and Drug Admin-
istration hearing held in October 2006 it was reported
that 21 studies had been conducted, were underway or
about to commence[23].
In Europe, RWC in emergency situations was permissible
in many countries but in 2004 the European Union Direc-
tive [24] on clinical research became law across the (then)
25 EU member states. The Directive which was introduced
to 'simplify and harmonise the regulation of clinical trials
across the EU' [25] makes no provision for RWC in emer-
gency situations. Although at variance with the Directive,
Austria, Belgium, France, The Netherlands, Germany and
Spain retained their existing national legislation for emer-
gency research: Denmark, Italy, Ireland, Portugal and the
UK attempted to adhere to the rules of the Directive [26].
At the end of 2006 the UK issued an amendment to the
Clinical Trials Directive [27] to permit RWC in emergency
situations with ethical committee approval.
Legislation has been implemented to protect patients and
facilitate acute research with adults who are unable to give
consent. Public involvement in health, social policy and
practice is already well established in the UK [28] and
researchers are increasingly expected to involve the public
in all stages of the research process. Yet to date the views
of patients and the public have not been considered when
developing research legislation[29]. This paper reviews
research examining public opinion regarding RWC in
emergency situations, and whether the rules and regula-
tions permitting research of this kind are in accordance
with the views of those who ultimately may be the most
affected.
Methods
Seven electronic databases – Medline, Embase, CINAHL,
Cochrane Database of Systematic Reviews, Philosopher's
Index, Age Info, PsychInfo, Sociological Abstracts and
Web of Science – were searched up to the end of May
2007. The search terms are listed in Table 1. Searches were
conducted by JL and articles were individually reviewed
by both JL and MM. Any queries over the suitability of
studies for inclusion were resolved by a third person (HR).
Only those articles pertaining to the views of the public in
the US, Canada and EU member states regarding research
in an emergency setting involving adults were included.
Opinion pieces and those not published in English were
excluded. We recognise the important issues relating spe-
cifically to obtaining consent from parents to enrol their
children in paediatric research but feel they are beyond
the scope of this review.BMC Medical Ethics 2008, 9:9 http://www.biomedcentral.com/1472-6939/9/9
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Results
Using the terms relating to emergency research and
patient/public opinion (Table 1) we elicited 7298 and
13224 articles respectively in the Medline search. Com-
bining these terms resulted in a total of 28 papers; from
the titles 24 were deemed to be unsuitable for the review.
The search was exploded to ensure greater coverage and a
further seven papers were identified using the terms
'emergency research', 'emergency exception' and 'excep-
tion from informed consent'. Two further relevant papers
were identified from searching the references lists of key
articles. Searches in the other databases listed did not elicit
any new papers suitable for this review.
Public attitudes
A search of the published research literature identified six
surveys specifically exploring public attitudes to clinical
research on human subjects without consent (Tables 2
and 3). One was conducted in the UK[30], the rest in the
US[29,31-34]. Two studies canvassed the views of emer-
gency department (ED) patients solely[29,33]; two of ED
patients and visitors [31,34]; one of patients from the ED
and a geriatric clinic[32]; and one of attendees at an out-
patient department[30]. Four of the six sought opinions
regarding RWC generally: all asked if the respondent per-
sonally would be happy to participate in a study where
consent was not obtained. Hypothetical scenarios or
descriptions of medical situations where obtaining con-
sent would be difficult were used. Some scenarios intro-
duced the issue of minimal and more than minimal risk.
In the two studies of ED patients and visitors[31,34],
around half supported RWC but the proportions happy to
take part in such a study differed (70% v 50%). Partici-
pants in the UK study responded more positively to RWC,
but favoured a 'deferred' approach, suggesting consent
should be obtained from a relative (82%) or the patient
(90%) as soon as possible following recruitment to the
trial[30]. The authors point out their sample of out-
patients may respond more positively to the concept than
those who are not regularly attending hospital. The major-
ity of ED patients stated they would participate without
consent but the proportions ranged from 57%[33] (risk
not specified) to 73%[29] and 88%[32] (minimal risk).
For patients attending a geriatric clinic, support for RWC
decreased from 67% to 48% and for ED patients 83% to
70% when the experimental drug was being tested as part
of a randomised controlled trial rather than 'outside' of a
study protocol[32]. As participants had a high level of
trust in their doctor to act in the patients' best interest
(91–97%), the authors state these findings may reflect dis-
trust of the research process. The association between
degree of risk and agreement with RWC demonstrated in
three of the studies[29,32,30] is supported by a focus
group study where the levels of risk described in the study
scenarios were shown to have a bearing on public atti-
tudes, as was benefit and personal experience of research
or health professionals (directly or through a family mem-
ber)[35].
Other studies were identified where – although not the
main focus – data relating to RWC was collected. Two UK
studies were identified involving consumers in the design
of an RCT: participants supported a waiver of consent pro-
cedure for incapacitated patients for a hypothetical
thrombolysis trial but only in the absence of a relative
willing to act as a proxy[36] whilst for a lower risk trial to
evaluate routine oxygen supplementation there was
greater agreement with waiver of consent because of a rec-
ognition of the stress of decision making upon relatives at
a difficult time[37].
Another source of information is the data collected from
community consultation, a regulatory requirement of
exception from informed consent in the US. To canvass
public views, one recently published study sampled three
sets of community representatives (1136) and found that
over half (58%) agreed that waiver of consent was justi-
fied in that particular project which the authors describe
as low risk[38]. A qualitative study conducted to ascertain
the preferences of (12) stroke patients' and their family
members about consent in emergency research reported
all but one were happy for the doctor to make the decision
about enrolment to the trial in the absence of a surrogate
to provide informed consent[39]. Analysis of community
consultation data revealed one public concern was that
Table 1: Search terms used
patient* views OR
emergency research OR patient* perception* OR
emergency medicine OR patient* opinion* OR
exception from informed consent OR AND patient* attitude* OR
waiver of informed consent OR public* views OR
emergency exception OR public* perception* OR
resuscitation research public* opinion* OR
public* attitude*BMC Medical Ethics 2008, 9:9 http://www.biomedcentral.com/1472-6939/9/9
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there should be an opt-out mechanism to allow prospec-
tive refusal or the identification of uninterested
patients[40].
Despite the fact that clinical research involving humans
has been permitted without consent for many years – over
10 years in the US using the Exception and Waiver regula-
tions – we were unable to identify any papers reporting
the views of patients (or of their relatives) involved in any
of these studies. Data has been collected regarding the
views of families whose relatives were involved in studies
using deferred consent. This approach (sometimes
referred to as 'retrospective consent') depends upon
obtaining consent from the patient or legal representative
after the patient has been entered into the trial[41]. The
consent – when it is obtained – is actually consent to
remain in the study. In one study, out of 531 patients
enrolled using this approach, only six families reacted
negatively[42]. In 1993 deferred consent was deemed no
longer acceptable under USA regulations[43] because it
was not legally equivalent to informed consent[44].
There are published studies exploring the perspectives of
those approached in an acute situation for research partic-
Table 2: Studies reporting public opinion of research without consent – Aspects of study design
Author Country Study design Sample No of 
subjects
Scenarios/hypothetical 
studies
Measurements
Smithline & Gerstle (1998) [29] US Interview 
survey
Emergency 
Dept pts
204 Patient had serious illness Agree/disagree
1. Study intervention with 
minimal absolute risk
2. Study intervention with 
greater than minimal 
absolute risk
McClure et al (2003) [31] US Interview 
survey
Emergency 
Dept pts & 
visitors
530 1. Study intervention with 
minimal absolute risk
5-point Likert scale
2. Study intervention with 
greater than minimal 
absolute risk
Two study scenarios:
1. New therapies for serious 
bleeding
2. Efficacy of public access to 
defibrillation
Abboud et al (2006) [32] US Interview 
survey
Emergency 
Dept pts
207 Patient in cardiac arrest
Geriatric 
Clinic pts
213 Two surgical procedures:
1. Less invasive, intravenous 
line (minimal risk)
4-point Likert scale
2. More invasive, 
thoracotomy (>minimal risk)
New experimental medicine 
in three study designs:
1. Outside of a study 
protocol;
2. Part of a study protocol;
3. In a randomised controlled 
trial
Goldstein et al (2007). [33] US Interview 
survey
Emergency 
Dept pts
473 Patient suffered cardiac 
arrest or stroke
Not stated
Triner et al (2007) [34] US Interview 
survey
Emergency 
Dept pts & 
visitors
497 General description of 
waiver of and exception from 
informed consent studies
5-point Likert scale
Booth et al (2005) [30] UK Self-
completion 
questionnaire
Out-patients 362 Patient suffered heart attack, 
stroke or head injury
Yes/No/Don't know
1. Study intervention with 
minimal risk
2. Study intervention with 
moderate riskBMC Medical Ethics 2008, 9:9 http://www.biomedcentral.com/1472-6939/9/9
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ipation with regard to informed consent. One study of
181 patients with acute myocardial infarction reported
less than half (41%) found it acceptable to have to decide
whether or not to enrol in those circumstances[45]. In the
open comments, those who did not find it acceptable gave
the following reasons: 'it was impossible to make a deci-
sion under the circumstances; that they did not want to be
asked to make any decisions under the circumstances; or
that they did not approve of the randomisation'. Of those
who thought it unacceptable only two felt the decision
Table 3: Studies reporting public opinion of research without consent – Findings
Author Sample No of 
subjects
% agreed 
with RWC
% would personally be enrolled without 
consent
Factors measured
risk not 
specified
minimal 
risk 
research
> minimal 
risk 
research
associated 
with 
attitude to 
RWC
not 
associated
Smithline & 
Gerstle 
(1998) [29]
Emergency 
Dept pts
204 - - 73 50 Educational 
status and 
certain 
aspects of 
health status
Age, race, 
gender, 
perception of 
current acute 
illness.
McClure et al 
(2003) [31]
Emergency 
Dept pts & 
visitors
500+ 34 70 75 50 Race Gender, 
religion, 
education, 
insurance 
status, 
knowledge of 
resuscitation 
medicine.
Abboud et al 
(2006) [32]
Emergency 
Dept pts
207 - 70 88 77 Study design, 
invasiveness 
of 
intervention, 
patient group
Age, race; 
marital status, 
living 
situation, 
religion, 
church 
attendance, 
education, 
having an 
advance 
directive
Geriatric 
Clinic pts
213 48 63 48 Geriatric 
clinic patients 
only – gender 
and health 
status
Goldstein et 
al (2007). [33]
Emergency 
Dept pts
473 51 57 - - Age, gender, 
race, 
ethnicity, 
education, 
insurance 
status, 
religion, 
confidence in 
current 
therapies & 
knowledge of 
requirements 
for RWC 
studies
Triner et al 
(2007) [34]
Emergency 
Dept pts & 
visitors
497 42 50 - - Age, Gender, 
ethnicity
Marital status, 
education.
Booth et al 
(2005) 12
Out-patients 362 84 - 92 67 None 
reported
None 
reported
not measuredBMC Medical Ethics 2008, 9:9 http://www.biomedcentral.com/1472-6939/9/9
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should rest with a physician. In a qualitative study of 31
patients' experiences of the consent procedure in an acute
myocardial infarction trial the majority would have been
willing for a physician to make the decision had they been
too ill to approach for consent [46].
Protection of subjects in the absence of informed consent
Community consultation
One requirement of the Waiver of, and Exception from,
Informed Consent regulations in the US is community
consultation, a two-way communication between the
community and research team. Proposed as an additional
protection for patients, its purpose is to elicit the opinions
and obtain input from the community where the research
will be conducted, about the proposed study and the
exception from informed consent. This information is fed
back to the Institutional Review Board for consideration
before the study is approved [40]. Despite the fact there is
no clearly defined or published regulatory intent, those
working in the field of emergency medicine have prof-
fered their own interpretations of community consulta-
tion. It has been considered to be a means of promoting
trust within the community [8]. In the absence of the one
to one encounter between participant and researcher
under 'normal' conditions, the latter can disclose details
of the project to members of the community, document
and respond to any concerns [47]. An assumed benefit is
that this will deter researchers from planning to conduct
research of which they fear the public may disap-
prove[48]. This exercise has generated a significant
amount of published literature, especially in relation to
problems with its implementation [35,38,47,49-52]
As researchers are not required to demonstrate how suc-
cessful this exercise has been, little has been published
about its efficacy or its acceptability to the general public.
One focus group study asked participants to consider how
researchers should proceed with research when the poten-
tial subject cannot give consent, has no family member
and there is no time to contact anyone[35]. The authors
reported that the participants struggled with this concep-
tually and 'the facilitator had to repeatedly refocus the
participants on this issue.'. This raises the question that if
members of the community have this problem in focus
groups how will others fare in large public meetings where
they may have less time and less opportunity to gain a full
understanding of research without consent and the situa-
tions that demand it. A survey reported that 5% of the 530
ED respondents to the survey were aware of current
research in their community using the exception from
informed consent[31]. Respondents were also asked if
they regarded community consultation and public notifi-
cation as a reasonable substitute for patient consent,
although within the FDA regulations this is not the inten-
tion. However, 45% agreed that these exercises were a rea-
sonable substitute for patient consent and 49% would
attend a community meeting. As the authors state, in the
light of these findings community consultations may not
be the most effective method of meeting the ethical
requirements of the regulations. In the UK – where com-
munity consultation is not a requirement for emergency
research – 62% of patients surveyed felt public meetings
were a practical way forward and 35% stated they would
attend[30].
Discussion
The available data from the US reveals around half of
those surveyed do not agree generally with research with-
out consent in emergency situations [31,34,33,35]. Para-
doxically, however, a higher percentage would personally
take part in such a study. Unfortunately the studies were
not designed to investigate in any depth individuals' views
regarding participation in studies where consent was
waived. The association between level of risk, or invasive-
ness of study intervention, and support for research with-
out consent is understandable, but that with study design
is not. Patients were more likely to accept an experimental
treatment 'outside' of a research protocol without giving
consent than in a randomised controlled trial, but again it
is not known why this is so. In reality, patients who par-
ticipate in an organised research study that has undergone
scientific and ethical review are more protected than those
whose doctor prescribes a treatment unproven with their
condition[32]. However, it is not clear whether the public
are aware of the protections in place. One explanation is
that the use of randomisation may be problematic for the
lay person. Concern about randomisation and a prefer-
ence for the doctor to choose treatment have been most
commonly cited as reasons for refusing to enrol in one
study[53]. It is not clear whether this stemmed from a lack
of, or a full understanding of randomisation. In another
trial the authors felt that some of their study respondents
fully understood but disliked and resisted concepts such
as placebo and randomisation, for example[54]. They
believe this may be because the idea that the physician
does not know – or knows and does not randomise them
to – the 'best' treatment, sits uncomfortably with some
people and conflicts with their views of, and trust in, med-
ical care.
Considering the wealth of literature on the perspectives of
professionals, ranging from bio-ethicists to physician
investigators, there is relatively little information about
public attitudes toward research without consent or of
their views on how to engender the development of new
treatments whilst protecting vulnerable participants. Rea-
sons for a lack of support for research without consent
may be due to a general lack of awareness of how few
treatment options available there are for some conditions
and that many current therapies are poorly supported byBMC Medical Ethics 2008, 9:9 http://www.biomedcentral.com/1472-6939/9/9
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evidence or have poor outcomes[23], although research in
this area is scarce. This is an interesting point, however,
considering the backlash against protectionism with some
AIDS and cancer sufferers demanding the right to partici-
pate in clinical trials of new medications[55].
Additionally, though there are very few data from other
countries with which to draw comparisons, the American
public may be more suspicious and less supportive of
medical research. A US focus group study published in
2005 reported that participants were aware of incidences
of unethical research but felt these were now "less com-
mon" and that "research ethics had improved"[35]. Par-
ticipants in the same study also believed that medical staff
often used any surplus blood for research without inform-
ing the patient or seeking their permission. A focus group
study of ED patients and visitors reported that almost half
(49%) equated research participants to 'human guinea
pigs'[56].
There are too few data to evaluate whether the US commu-
nity consultation requirement protects – or is acceptable
to – study participants and there is a need for research in
this area. The only concern in relation to research without
consent identified from communications with the public
was a system to opt out. There is some public support for
patients' wishes regarding research participation to be
recorded on cards or wristbands[32].
Professionals believe that too much emphasis is placed on
informed consent, which does not in itself guarantee eth-
ical research[57-59]. Those advocating a move from a reli-
ance on informed consent as a protection for research
subjects suggest improved study design to ensure ethical
clinical research[60]. The ethics of clinical research should
be judged on: the value of the research; scientific validity;
fair subject selection; favourable risk-benefit ratio; inde-
pendent review; informed consent; and respect for partic-
ipants [58,61]. Although still part of the ethical
framework, when circumstances preclude obtaining
informed consent there should be clinical equipoise
which will ensure 'the subject is not worse off by enroll-
ing'[58]. Clearly these should be standard requirements of
every research study but they may not go far enough to sat-
isfy those opposed to, or uncomfortable with, research
without consent.
For research without consent to be accepted as a necessity
in certain circumstances we suggest there is a need for
public involvement in the debate. Any programmes of
involvement need to attend to the apparently paradoxical
findings of some of the current surveys. For example, if
people are more likely to accept experimental treatments
outside of a research environment than within one, we
clearly need to increase public trust in medical research.
This may be bolstered by providing information about the
rationale for certain study designs, and highlighting the
ethical assessments that clinical trials currently undertake
to be approved. We may also need to increase awareness
of the standard and efficacy of current therapies and of the
necessity to evaluate and develop new ones within the
framework of randomised controlled trials. Additionally,
a system that enables people to opt out of clinical research
might be another measure to reassure the public and pro-
tect patient autonomy but this warrants further investiga-
tion. However, any attempts to engage the public in such
a programme of the 'public understanding of research',
should take place in the context of findings from further
basic research. We need to understand the factors that pro-
mote and inhibit trust in experimental treatments and the
potential concerns that patients and the public have
around such treatments in randomized controlled trials.
The findings from the survey research raised other inter-
esting issues. Firstly a survey in the UK found that two-
thirds of people felt that community consultation could
be a practical solution but significantly less of them were
willing to attend such meetings. So actually undertaking a
community consultation that produces 'democratic' and
'representative' directives for research without consent
appears problematic from the outset. Secondly, a survey
in the US found that more people were willing to take part
in a study when speaking about 'themselves' – when
thinking about whether they would personally take part –
than when speaking in general terms. When people think
about experimental treatments in relation to a potential
future moment in their own illness biography they are a
lot more accepting of research without consent. We need
to be aware of how we frame our research questions and
how respondents are making sense of them – are we ask-
ing them to offer their views about research without con-
sent in relation to different potential illness episodes
involving them or a significant other, or at a more abstract
level, about their 'faith' in the idea of research without
consent. Additionally, how does this relate to the ideals of
experimental research, that people should not be encour-
aged to take part for personal benefit per se but rather to
enable the future benefit of future patients? Finally, no
research has focused on the experiences and views of
patients who have actually taken part in research without
consent. Rather than solely relying on people engaging in
hypothetical 'thought experiments', it is essential to gen-
erate additional evidence from patients enrolled in such
studies to help to inform the continuing ethical dilemma
of research without consent.
Conclusion
The question as to whether current rules and regulations
permitting research without consent is acceptable to, or
protects, the public remains unanswered. We suggest thereBMC Medical Ethics 2008, 9:9 http://www.biomedcentral.com/1472-6939/9/9
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is a need for accessible and comprehensive public infor-
mation about medical research and for public involve-
ment in the debate surrounding research without consent.
Before this happens, however, we must understand the
factors that influence patient and public trust in medical
research.
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